Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders.
McClure
R
R
Mai
M
M
Lasho
T
T
D019943:Amino Acid Substitution / Q000235:genetics; D002908:Chronic Disease; D004252:DNA Mutational Analysis / Q000379:methods*; D006801:Humans; D053614:Janus Kinase 2; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D013696:Temperature
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2